Healthdirect Free Australian health advice you can count on.

Medical problem? Call 1800 022 222. If you need urgent medical help, call triple zero immediately

healthdirect Australia is a free service where you can talk to a nurse or doctor who can help you know what to do.

beginning of content

Brand name: Humira

Humira is a medicine containing the active ingredient(s) adalimumab. On this page you will find out more about Humira, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.

Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.

Active ingredient in this medicine: adalimumab

Pack size information

Please select the pack size from the options directly below to view information on the medicine.

Information for medicine and pack size:
Humira 40 mg/0.8 mL injection solution, 2 x 0.8 mL syringes

Consumer Medicine Information leaflet:

This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.

Read leaflet

What this medicine is for

Rheumatoid Arthritis: Humira is indicated for reducing signs and symptoms, as well as inhibiting the progression of structural damage in adult patients with moderate to severely active rheumatoid arthritis. This includes the treatment of patients with recently diagnosed moderate to severely active disease who have not received methotrexate. Humira can be used alone or in combination with methotrexate.,Juvenile Idiopathic Arthritis: - Polyarticular Juvenile Idiopathic Arthritis: Humira in combination with methotrexate is indicated for reducing the signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older who have had an inadequate response to one or more disease modifying anti-rheumatic drugs (DMARDs). Humira can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate. - Enthesitis-Related Arthritis: Humira is indicated for the treatment of enthesitis-related arthritis in children, who have had an inadequate response to, or who are intolerant to, conventional therapy.,Psoriatic Arthritis: Humira is indicated for the treatment of signs and symptoms, as well as inhibiting the progression of structural damage, of moderate to severely active psoriatic arthritis in adult patients where response to previous DMARDs has been inadequate.,Ankylosing Spondylitis: Humira is indicated for reducing signs and symptoms in patients with active ankylosing spondylitis.,Crohn's Disease in adults and Children (6 years and older): Humira is indicated for the treatment of moderate to severe Crohns disease, to reduce the signs and symptoms of the disease and to induce and maintain clinical remission in patients; - who have had an inadequate response to conventional therapies or, - who have lost response to or are intolerant of infliximab.,Ulcerative colitis: Humira is indicated for the treatment of moderate to severe ulcerative colitis in adult patients who have had an inadequate response to conventional therapy or who are intolerant to or have medical contraindications for such therapies. Patients should show a clinical response within 8 weeks of treatment to continue treatment beyond that time. (see CLINICAL TRIALS).,Psoriasis in adults and children: Humira is indicated for the treatment of moderate to severe chronic plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy. Humira is indicated for the treatment of severe chronic plaque psoriasis in children and adolescent patients from 4 years of age who have had an inadequate response to or are inappropriate candidates for topical therapy and phototherapy.,Hidradenitis Suppurativa: Humira is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in adult patients with an inadequate response to conventional systemic hidradenitis suppurativa therapy.,Uveitis: Humira is indicated for the treatment of non-infectious intermediate, posterior and pan-uveitis in adult patients who have had an inadequate response to corticosteroids, in patients in need of corticosteroid sparing, or in whom corticosteroid treatment is inappropriate.

Table of characteristics
Table of characteristics
Active ingredient
Visual appearance Aqueous solution practically free from visible particles
Dosage Form Injection, solution
Route of administration Subcutaneous
Medicine schedule
1 prefilled syringe: Prescription Only Medicine, or Prescription Animal Remedy
2 prefilled syringes: Prescription Only Medicine, or Prescription Animal Remedy
3 prefilled syringes: Prescription Only Medicine, or Prescription Animal Remedy
4 prefilled syringes: Prescription Only Medicine, or Prescription Animal Remedy
6 prefilled syringes: Prescription Only Medicine, or Prescription Animal Remedy

There is one type of pack available.

Pack type 1
Pack type 1
Type Syringe
Storage temperature Store at 2 to 8 degrees Celsius
Storage conditions Refrigerate,Do not Freeze
Life time 24 Months
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on 1 October 2017

The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.

Go to PBS site

Is this medication banned in sport?

Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.

Go to ASADA site

The information displayed on this page is authored by Healthdirect Australia, or obtained from trusted sources.

Need more information?

These trusted information partners have more on this topic.

Found 10 results

Humira Prefilled syringe - myDr.com.au

Humira Prefilled syringe - Consumer Medicines Information leaflets of prescription and over-the-counter medicines

Read more on myDr – Consumer Medicine Information website

Biologic treatments used in dermatology - ACD

Biologics are medications made from human or animal proteins. They are designed to specifically target biologic pathways that cause inflammation in the skin and other organs.

Read more on Australasian College of Dermatologists website

Juvenile chronic arthritis - myDr.com.au

Juvenile chronic arthritis or juvenile idiopathic arthritis (JIA) is long-term joint inflammation (arthritis) in children. The main symptom is having painful joints for no obvious reason.

Read more on myDr website

Crohn's disease treatments - myDr.com.au

Medical treatment aims to control Crohn's disease symptoms and bring on a remission of the disease.

Read more on myDr website

Medication

This Information Sheet is about some of the common medications (drugs) used to treat autoimmune illness.

Read more on Autoimmune Resource and Research Centre website

Ulcerative colitis: treatment - myDr.com.au

Treatment of ulcerative colitis will depend on the severity of the disease, the effect the symptoms are having on your daily life and whether you are in remission or are having a flare-up.

Read more on myDr website

Psoriasis: what you need to know - myDr.com.au

Psoriasis is characterised by red scaly patches on the skin that may be sore or itchy. Although there is no cure for psoriasis, in most cases the disease can be well controlled.

Read more on myDr website

Xeljanz Tablets - myDr.com.au

Xeljanz Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines

Read more on myDr – Consumer Medicine Information website

Orencia Powder for infusion - myDr.com.au

Orencia Powder for infusion - Consumer Medicines Information leaflets of prescription and over-the-counter medicines

Read more on myDr – Consumer Medicine Information website

Simponi prefilled syringe Solution for injection - myDr.com.au

Simponi prefilled syringe Solution for injection - Consumer Medicines Information leaflets of prescription and over-the-counter medicines

Read more on myDr – Consumer Medicine Information website

Check your symptoms Find a health service

Healthdirect 24hr 7 days a week hotline

24 hour health advice and information you can count on

1800 022 222

Government Accredited with over 140 information partners

We are a government-funded service, providing quality, approved health information

Australian Government, health department logo ACT Government logo New South Wales government, health department logo Northen Territory Government logo Government of South Australia, health department logo Tasmanian government logo Government of Western Australia, health department logo
Feedback